Publikationen (138) Publikationen von LUIS MIGUEL ALLENDE MARTÍNEZ

2024

  1. Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity

    Journal of Clinical Immunology, Vol. 44, Núm. 3

  2. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

  3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  4. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  5. The lack of either IRF9, or STAT2, has surprisingly little effect on human natural killer cell development and function

    Immunology, Vol. 172, Núm. 3, pp. 440-450

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  3. Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children

    Journal of Clinical Immunology, Vol. 43, Núm. 6, pp. 1278-1288

  4. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095

  5. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy

    Journal of Clinical Immunology, Vol. 43, Núm. 1, pp. 165-180

  6. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  7. TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 736-747

  8. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

    Science immunology, Vol. 8, Núm. 90, pp. eabp8966

2022

  1. Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

  2. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution

    Biomedicines, Vol. 10, Núm. 2

  3. Eczematous dermatitis and thrombocytopenia in a 10-month-old boy

    JEADV Clinical Practice, Vol. 1, Núm. 1, pp. 62-65

  4. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  5. Human genetic and immunological determinants of critical COVID-19 pneumonia

    Nature, Vol. 603, Núm. 7902, pp. 587-598

  6. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency

    Journal of Clinical Immunology, Vol. 42, Núm. 2, pp. 240-252

2021

  1. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma

    Turkish journal of haematology : official journal of Turkish Society of Haematology, Vol. 38, Núm. 2, pp. 145-150